Free Republic 3rd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $35,360
43%  
Woo hoo!! And we're now over 43%!! Thank you all very much!! God bless.

Keyword: alexandrakoehn

Brevity: Headers | « Text »
  • Vanderbilt enrolling participants in ivermectin treatment study for COVID-19

    11/28/2021 2:28:17 PM PST · by Libloather · 27 replies
    News Channel 5 ^ | 11/23/21 | Alexandra Koehn
    NASHVILLE, Tenn. (WTVF) - Ivermectin, a drug that treats parasite infestations, is being studied at Vanderbilt as a possible treatment for COVID-19. **SNIP** Vanderbilt is participating in a national study on several treatments. In addition to ivermectin, they're also researching fluticasone, a nose spray for allergies commonly known as Flonase, and fluvoxamine. "It’s one of the older anti-depressants that have been out there a very long time," Goyal said. Fluvoxamine could have an anti-inflammatory effect according to the National Institutes of Health. Beth Winslow is vaccinated, had her booster shot, and still got COVID-19. She decided to enroll in the...